Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
A Pilot Double Blind Controlled Study Randomizing Patients Whose ENL is Not Controlled With Standard Prednisolone, and Comparing a Group Treated With Ciclosporin to a Group Treated With Additional Steroid Only.
Sponsor: Alert Hospital, Ethiopia
This PHASE2 trial investigates Leprosy and is currently completed. Alert Hospital, Ethiopia leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Aug 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alert Hospital, Ethiopia
- Armauer Hansen Research Institute, Ethiopia
- Homes and Hospitals of St Giles
- London School of Hygiene and Tropical Medicine
For direct contact, visit the study record on ClinicalTrials.gov .